A 93-year-old lady developed extensive skin lesions following treatment with ciprofloxacin for urinary tract infection. Skin biopsy confirmed toxic epidermal necrolysis. She died within 48 hours of onset of her skin signs in spite of active management. Toxic epidermal necrolysis is a rare but serious side-effect of ciprofloxacin.
A 93-year-old lady was admitted to an acute medical admission unit with evidence of urinary tract infection and septicaemia. She was also known to be allergic to penicillin, suffered with ischaemic heart disease and with hypertension. Her regular medication included aspirin, ramipril and isosorbide dinitrate. She was treated in the hospital with oral ciprofloxacin for her urinary tract infection. However, within 72 hours of commencing ciprofloxacin she became acutely unwell, developing bloody, crusted erosion of the peroral and nasal mucosa with large areas of superficially denuded skin over the face, arms, thighs and buttocks. She also developed flaccid blisters over the neck, back and upper limbs along with erythema over the abdomen. Sixty percent of her skin was involved within 24 hours of onset of cutaneous signs. She was febrile, tachycardic and delirious. A clinical diagnosis of toxic epidermal necrolysis (TEN) was made.
A skin biopsy was taken and the patient was transferred to the regional burns unit. Her management included pain control with opioid analgesia, management of nutrition and fluid input and supportive management. There was no evidence of sepsis and the patient was not given prophylactic antibiotics. Over the next 24 hours she remained haemodynamically unstable and developed multi-organ failure. She died within 48 hours of onset of cutaneous signs. The skin biopsy demonstrated a necrotic epidermis, split at the base from the dermis. The dermis showed perivascular mononuclear infiltrate and occasional macrophages containing brown pigments. This histological picture and clinical findings were consistent with a diagnosis of TEN.
Discussion
TEN or Lyll's syndrome is an idiosyncratic, severe systemic disease characterised by prodromal symptoms followed by a dramatic cutaneous sloughing of up to 100% of the body surface area. Mortality varies from 25% to 75% and increases with age. Average incidence is around 1/million persons in the western population with three-quarters of cases of TEN reported to be drug associated. However, other associations have been documented including immunisation, viral infection, graft versus host disease and connective tissue disorders. The pathogenesis of TEN is unclear. The histological findings of full-thickness epidermal necrosis imply that the epidermis is directly or indirectly the target of the disease process and most likely a T-cell mediated immune reaction.
Management of TEN is mainly supportive and the survival rate improves when the patient is managed in a burns unit or in the intensive therapeutic unit [1] [2] [3] . The role of systemic steroids is controversial and there is no evidence to suggest that it is beneficial in TEN. Prophylactic antibiotics and plasmapheresis are being used with variable results [1, 4] .
In this case, the patient was placed on ciprofloxacin 3 days prior to the onset of cutaneous signs and had not taken any other medications, including over-the-counter NSAIDs, known to cause TEN. The time course strongly suggests ciprofloxacin as the responsible agent [5] . Only a handful of cases have been reported in the medical literature, where ciprofloxacin has been implicated. The previous cases reported were between the ages of 31 years and 72 years [3] . To our knowledge this is the first reported case of ciprofloxacininduced TEN in a nonagerian. This well documented case adds to the evidence that TEN is a rare but serious side-effect of ciprofloxacin and the outcome may be fatal.
